A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Merck & Co., Inc. stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 5,912,044 shares of MRK stock, worth $587 Million. This represents 2.14% of its overall portfolio holdings.

Number of Shares
5,912,044
Previous 5,328,292 10.96%
Holding current value
$587 Million
Previous $660 Million 1.78%
% of portfolio
2.14%
Previous 2.26%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$111.15 - $128.97 $64.9 Million - $75.3 Million
583,752 Added 10.96%
5,912,044 $671 Million
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $74.4 Million - $79.9 Million
601,234 Added 12.72%
5,328,292 $660 Million
Q1 2024

May 14, 2024

BUY
$113.24 - $131.95 $79.4 Million - $92.5 Million
701,200 Added 17.42%
4,727,058 $624 Million
Q4 2023

Feb 13, 2024

SELL
$100.18 - $109.02 $306,350 - $333,383
-3,058 Reduced 0.08%
4,025,858 $439 Million
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $42.3 Million - $47 Million
411,073 Added 11.36%
4,028,916 $415 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $61.3 Million - $66.8 Million
564,296 Added 18.48%
3,617,843 $417 Million
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $9.19 Million - $10.3 Million
-89,264 Reduced 2.84%
3,053,547 $325 Million
Q4 2022

Feb 13, 2023

BUY
$87.44 - $112.11 $3.16 Million - $4.05 Million
36,156 Added 1.16%
3,142,811 $349 Million
Q3 2022

Nov 10, 2022

SELL
$84.53 - $94.96 $278,949 - $313,368
-3,300 Reduced 0.11%
3,106,655 $268 Million
Q2 2022

Aug 12, 2022

SELL
$83.49 - $94.64 $61.6 Million - $69.8 Million
-737,348 Reduced 19.17%
3,109,955 $284 Million
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $4.41 Million - $4.94 Million
59,929 Added 1.58%
3,847,303 $316 Million
Q4 2021

Feb 11, 2022

BUY
$72.28 - $90.54 $5.58 Million - $6.99 Million
77,162 Added 2.08%
3,787,374 $290 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $9.92 Million - $10.9 Million
138,334 Added 3.87%
3,710,212 $279 Million
Q2 2021

Aug 12, 2021

BUY
$70.31 - $77.77 $20.5 Million - $22.6 Million
291,195 Added 8.88%
3,571,878 $278 Million
Q1 2021

May 13, 2021

BUY
$68.86 - $81.11 $17.5 Million - $20.6 Million
254,063 Added 8.39%
3,280,683 $253 Million
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $858,082 - $952,295
11,956 Added 0.4%
3,026,620 $248 Million
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $4.03 Million - $4.57 Million
55,060 Added 1.86%
3,014,664 $250 Million
Q2 2020

Aug 13, 2020

SELL
$70.42 - $80.13 $6.16 Million - $7.01 Million
-87,498 Reduced 2.87%
2,959,604 $229 Million
Q1 2020

May 14, 2020

SELL
$63.36 - $87.82 $50 Million - $69.4 Million
-789,823 Reduced 20.58%
3,047,102 $234 Million
Q4 2019

Feb 13, 2020

SELL
$77.58 - $87.54 $5.82 Million - $6.56 Million
-74,970 Reduced 1.92%
3,836,925 $349 Million
Q3 2019

Nov 13, 2019

BUY
$76.08 - $82.93 $14.6 Million - $15.9 Million
191,749 Added 5.15%
3,911,895 $329 Million
Q2 2019

Aug 13, 2019

BUY
$69.84 - $81.59 $44.6 Million - $52.1 Million
639,128 Added 20.74%
3,720,146 $312 Million
Q1 2019

May 14, 2019

SELL
$69.58 - $79.36 $32.6 Million - $37.2 Million
-468,524 Reduced 13.2%
3,081,018 $256 Million
Q4 2018

Feb 13, 2019

SELL
$65.24 - $75.71 $27.6 Million - $32.1 Million
-423,445 Reduced 10.66%
3,549,542 $271 Million
Q3 2018

Nov 14, 2018

BUY
$57.69 - $67.84 $2.28 Million - $2.68 Million
39,511 Added 1.0%
3,972,987 $282 Million
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $58.9 Million - $69.2 Million
1,158,638 Added 41.76%
3,933,476 $239 Million
Q1 2018

May 15, 2018

BUY
$50.96 - $59.23 $116 Million - $135 Million
2,279,670 Added 460.38%
2,774,838 $151 Million
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $21.7 Million - $25.9 Million
420,368 Added 561.99%
495,168 $27.9 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $4.02 Million - $4.32 Million
68,500 Added 1087.3%
74,800 $4.79 Million
Q2 2017

Aug 14, 2017

BUY
N/A
6,300
6,300 $404,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track Jeremy Grantham's Portfolio

Track Jeremy Grantham Portfolio

Follow Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.